NEW YORK, Dec 27 - Lion Bioscience will acquire Trega Biosciences in a deal valued at $35 million, the companies announced Wednesday.

Under the terms of the agreement, Lion will issue new shares out of its authorized capital to acquire all outstanding shares of Trega in a stock-for-stock transaction using Lion's American Depositary Shares.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.